# Human Laboratory Study of Apremilast for Alcohol Use Disorder

> **NCT07325266** · PHASE2 · RECRUITING · sponsor: **National Institute on Alcohol Abuse and Alcoholism (NIAAA)** · enrollment: 100 (estimated)

## Conditions studied

- Alcohol Use Disorder
- Alcohol Misuse

## Interventions

- **DRUG:** Placebo
- **DRUG:** Apremilast

## Key facts

- **NCT ID:** NCT07325266
- **Lead sponsor:** National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-03
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07325266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07325266, "Human Laboratory Study of Apremilast for Alcohol Use Disorder". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07325266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*